CRH shares rise 4.4% after Q1 2026 beats expectations, guidance reaffirmed

CRH reported Q1 2026 results on Apr. 30, with revenue of $7.4 billion up 9% year over year and adjusted EBITDA of $600 million up 18%, lifting its EBITDA margin to 8% and prompting it to reaffirm full-year guidance. The stronger-than-expected report pushed the stock up 4.4% on the day. While CRH is down 10.3% year to date versus the S&P 500’s 9.1% gain, its nearly 27% return over the past 52 weeks slightly exceeds the index’s 25.2%. The shares trade below their 50-day and 200-day moving averages, while 21 analysts rate the stock “Strong Buy” with a mean price target of $146, implying 30.6% upside to current levels.